Minerva NeurosciencesNERV
13F holders, Q1 2024 (March 31)20holders
1famous investor
$2.58avg. 13F price*
At the end of Q1 2024, 20 institutions reported holding Minerva Neurosciences Inc. (NERV) in their 13F filings. The largest holders were Federated Hermes, Inc. ($3.5M), Vanguard Group Inc. ($650K) and Renaissance Technologies ($459K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Minerva Neurosciences Inc.
- CUSIP
- 603380205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $43K |
| Exits | 1 | $3.0M |
Ownership 20 holders
| Federated Hermes, Inc. | 0.01% | No change | 1,351,275 | $3.5M |
| Vanguard Group Inc. | 0.00% | Add +22.9% | 252,060 | $650K |
| Renaissance Technologies | 0.00% | Add +65.8% | 177,765 | $459K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.01% | Add +54.1% | 99,644 | $257K |
| BlackRock Inc. | 0.00% | No change | 72,669 | $187K |
| Geode Capital Management, LLC | 0.00% | Add +1.0% | 52,592 | $136K |
| Northern Trust Corp. | 0.00% | Reduce -7.6% | 23,086 | $60K |
| Acadian Asset Management LLC | 0.00% | No change | 17,423 | $44K |
| Susquehanna International Group, LLP | 0.00% | New | 16,681 | $43K |
| State Street Corp. | 0.00% | No change | 16,519 | $43K |
| Morgan Stanley | 0.00% | Add +71.0% | 10,747 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +201.7% | 4,103 | $11K |
| Wells Fargo & Company | 0.00% | Add +50.6% | 2,981 | $8K |
| Russell Investments Group, Ltd. | 0.00% | No change | 1,175 | $3K |
| Royal Bank of Canada | 0.00% | Add +11.1% | 549 | $1K |
| TFC Financial Management, Inc. | 0.00% | No change | 186 | $480 |
| Bank of America Corp. | 0.00% | Reduce -2.3% | 125 | $322 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 100 | $258 |
| Sandy Spring Bank | 0.00% | New | 100 | $258 |
| UBS Group AG | 0.00% | Reduce -84.6% | 10 | $26 |
"% of holder's portfolio" is NERV's weight in each manager's 13F, not the share of Minerva Neurosciences Inc. the manager owns.